Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Infinimmune
company
About
Infinimmune operates as a biotechnology company.
- San Francisco,California,United States
- 1 - 10
- https://www.infinimmune.com/
Highlights
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $12M
- Industries
- Biotechnology,Health Care,Life Science,Medical
- Founded date
- Jan 1, 2022
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Infinimmune operates as a biotechnology company. Infinimmune reinvents antibody discovery with an end-to-end platform to deliver antibody drugs derived directly from the human immune system.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$12M
Infinimmune has raised a total of
$12M
in funding over 2 rounds. Their latest funding was raised on
Dec 6, 2022 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 6, 2022 | Seed | $12M | 9 |
Playground Global
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
9
Infinimmune is funded by 9 investors.
Playground Global
and Axial VC
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Playground Global
|
Yes | Seed |
Axial VC
|
— | Seed |
Benjamin Kim
|
— | Seed |
Civilization Ventures
|
— | Seed |
Jacob Becraft
|
— | Seed |
Joshua Meier
|
— | Seed |
Paul Conley
|
— | Seed |
|
|
— | Seed |
Ron Alfa
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
